Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting
Authors not listed
Klinikum Bremen-Mitte, gGmbH · 2008
Abstract
The study is designed to demonstrate the therapeutic non-inferiority of the recombinant humanized monoclonal VEGF antibody bevacizumab administered by intravitreal injection in the treatment of AMD in comparison to the related fragment ranibizumab.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2008). Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting. <em>Klinikum Bremen-Mitte, gGmbH</em>. https://clinicaltrials.gov/study/NCT00559715
Vancouver
Anonymous. Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting. Klinikum Bremen-Mitte, gGmbH. 2008.
BibTeX
@misc{anon2008Preven,
title = {Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting},
author = {Anonymous},
journal = {Klinikum Bremen-Mitte, gGmbH},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.